冠動脈ステントの世界市場ー産業および機会分析ー2016-2026:薬剤溶出型ステント(DES)、ベアメタルステント(BMS)、生体吸収性脈管用ステント(BVS)

◆英語タイトル:Coronary Stents Market: Global Industry Analysis and Opportunity Assessment 2016-2026
◆商品コード:FMI612040
◆発行会社(調査会社):Future Market Insights
◆発行日:2016年10月14日
◆ページ数:206
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Individual (single user)USD5,000 ⇒換算¥550,000見積依頼/購入/質問フォーム
EnterpriseUSD10,000 ⇒換算¥1,100,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

A coronary stent is a small cylindrical device used during percutaneous coronary intervention (PCI). Coronary stents help relieve the symptoms of coronary heart disease by reducing blockages and improving blood flow to the heart. They are beneficial for patients suffering from coronary artery diseases such as myocardial infarction and unstable angina. The global coronary stents market is estimated to be valued at US$ 11.32 Bn by 2026, registering a CAGR of 6.6% over the forecast period.
Increasing prevalence of cardiovascular diseases expected to drive overall market growth

The global coronary stents market is driven by an increasing occurrence of lifestyle diseases such as obesity and cardiovascular diseases such as angina pectoris and ischemic heart disease especially in developed countries. Also, an increasing meditech progress in the cardiovascular field is expected to drive the growth of the global coronary stents market during the forecast period. Cardiologists the world over prefer advanced stenting procedures and this is another important factor boosting market growth. However, various complications and risks associated with stenting procedures and high costs of drug eluting stents is expected to adversely affect the revenue growth of the global coronary stents market over the forecast period.

Market segmentation

By Product Type

By Raw Material

By End Use

By Region

Drug Eluting Stent

Bare Metal Stent

Bioresorbable Vascular Stent

Cobalt Chromium

Stainless Steel

Platinum-Chromium

Nickel-Titanium

Polymer

Hospitals

Ambulatory Surgical Centres

Cardiac Catheterisation Laboratories

North America

Latin America

Western Europe

Eastern Europe

APEJ

MEA

Japan

Drug Eluting Stent product type segment estimated to account for significant market share by 2016 end

The Drug Eluting Stent segment is anticipated to account for 75.6% value share of the global coronary stents market by the end of 2016. This segment is expected to register a CAGR of 6.8% in terms of value over the forecast period. The Bioresorbable Vascular Stent segment is projected to register a CAGR of 9.4% between 2016 and 2026 and reach a market valuation of US$ 1,617.6 Mn by 2026.

Polymer raw material segment likely to be the most lucrative segment

The Polymer segment is expected to register high Y-o-Y growth throughout the forecast period and is expected to be valued at US$ 4,215.6 Mn by 2026, registering a CAGR of 9.2% during the forecast period. The Cobalt Chromium segment is estimated to account for 21.4% market share of the global coronary stents market by the end of 2016.

Hospitals end use segment expected to dominate the global coronary stents market in terms of value

The Hospitals segment is estimated to be valued at US$ 7,851.8 Mn by 2026, registering a CAGR of 6.3% during the forecast period. The Cardiac Catheterisation Laboratories segment is estimated to account for 19.8% revenue share by 2016 end.

APEJ market likely to register significant Y-o-Y growth throughout the forecast period

The APEJ coronary stents market is expected to hold 36.8% revenue share of the global coronary stents market by 2026. The APEJ market is expected to witness a CAGR of 8.0% during the forecast period. The North America market is anticipated to account for 29.2% market share of the global coronary stents market by 2016 end. Revenue from the North America market is projected to register a CAGR of 6.9% during 2016–2026, to reach a market valuation of US$ 3,426.0 Mn by 2026.

coronary stents market

Global coronary stents market players are focussing on product innovation and geographical expansion to augment market share

Terumo Corporation, Boston Scientific Corporation, Medtronic, Vascular Concepts, B. Braun Melsungen AG, Biotronik SE & Co. KG, Abbott Laboratories, Biosensors International Group, Ltd., Hexacath, and Stentys SA are some of the top companies operating in the global coronary stents market. Key market players are focussing on increasing their footprints in emerging markets such as Asia Pacific and are expanding their manufacturing facilities and distribution network to gain a larger share of the global coronary stents market.

Abbott Laboratories, Medtronic, and Boston Scientific Corporation emerged as the market leaders in the global coronary stents market for both the Drug Eluting Stent and Bare Metal Stent segments in 2015. The top three market players are estimated to hold more than 70% revenue share of the global coronary stents market in 2016. Abbott Laboratories accounted for the largest share in the global coronary stents market in 2015. Boston Scientific Corporation held maximum revenue share in Brazil in 2015. The company has a strong foothold in the domestic market of Latin America, particularly in the rapidly growing cardiovascular devices market in Brazil and other emerging countries.

【レポートの目次】

Table Of Content
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Coronary Stents Market Introduction

4.1. Market Definition

4.2. Market Taxonomy

5. Coronary Stents Market Analysis Scenario

5.1. Coronary Stents Market Size (US$ Mn) and Forecast

5.1.1. Market Size and Y-o-Y Growth

5.1.2. Absolute $ Opportunity

5.2. Coronary Stents Market Overview

5.2.1. Value Chain

5.2.2. Epidemiology of Cardiovascular Diseases

5.2.3. Key Regulations and Reimbursement Scenario

5.2.4. PEST Analysis

6. Coronary Stents Market Dynamics

6.1. Macro-economic Factors

6.2. Drivers

6.2.1. Supply Side

6.2.2. Demand Side

6.3. Restraints

6.4. Opportunity

6.5. Trends

7. Global Coronary Stents Market Analysis and Forecast, By Product

7.1. Introduction

7.1.1. Basis Point Share (BPS) Analysis By Product

7.1.2. Y-o-Y Growth Projections By Product

7.2. Market Size (US$ Mn) and Volume (Units) Forecast By Product

7.2.1. Drug Eluting Stent (DES)

7.2.2. Bare Metal Stent (BMS)

7.2.3. Bioresorbable Vascular Stent (BVS)

7.3. Global Coronary Stents Market Attractiveness Analysis, By Product Type

8. Global Coronary Stents Market Analysis and Forecast, By Raw Material

8.1. Introduction

8.1.1. Basis Point Share (BPS) Analysis By Raw Material

8.1.2. Y-o-Y Growth Projections By Raw Material

8.2. Market Size (US$ Mn) Forecast By Raw Material

8.2.1. Cobalt Chromium

8.2.2. Stainless Steel

8.2.3. Platinum – Chromium

8.2.4. Nickel – Titanium

8.2.5. Polymer

8.3. Global Coronary Stents Market Attractiveness Analysis, By Raw Material

9. Global Coronary Stents Market Analysis and Forecast, By End User

9.1. Introduction

9.1.1. Basis Point Share (BPS) Analysis By End User

9.1.2. Y-o-Y Growth Projections By End User

9.2. Market Size (US$ Mn) Forecast By End User

9.2.1. Hospitals

9.2.2. Ambulatory Surgical Centers

9.2.3. Cardiac Catheterization Laboratories

9.3. Market Attractiveness Analysis By End User

10. Global Coronary Stents Market Analysis and Forecast, By Region

10.1. Introduction

10.1.1. Basis Point Share (BPS) Analysis By Region

10.1.2. Y-o-Y Growth Projections By Region

10.2. Market Size (US$ Mn) Forecast By Region

10.2.1. North America

10.2.2. Latin America

10.2.3. Brazil

10.2.4. Western Europe

10.2.5. Eastern Europe

10.2.6. Asia Pacific Excluding Japan

10.2.7. Japan

10.2.8. Middle East and Africa (MEA)

10.3. Market Attractiveness Analysis By Region

11. North America Coronary Stents Market Analysis and Forecast

11.1. Introduction

11.1.1. Basis Point Share (BPS) Analysis By Country

11.1.2. Y-o-Y Growth Projections By Country

11.2. Market Size (US$ Mn) Forecast By Country

11.2.1. U.S.

11.2.2. Canada

11.3. Market Size (US$ Mn) Forecast By Product

11.3.1. Drug Eluting Stent (DES)

11.3.2. Bare Metal Stent (BMS)

11.3.3. Bioresorbable Vascular Stent (BVS)

11.4. Market Size (US$ Mn) Forecast By Raw Material

11.4.1. Cobalt Chromium

11.4.2. Stainless Steel

11.4.3. Platinum – Chromium

11.4.4. Nickel – Titanium

11.4.5. Polymer

11.5. Market Size (US$ Mn) Forecast By End User

11.5.1. Hospitals

11.5.2. Ambulatory Surgical Centers

11.5.3. Cardiac Catheterization Laboratories

11.6. Market Attractiveness Analysis

11.6.1. By Country

11.6.2. By Product

11.6.3. By Raw Material

11.6.4. By End User

11.7. Prominent Trends

11.8. Drivers and Restraints: Impact Analysis

12. Latin America Coronary Stents Market Analysis and Forecast

12.1. Introduction

12.1.1. Basis Point Share (BPS) Analysis By Country

12.1.2. Y-o-Y Growth Projections By Country

12.2. Market Size (US$ Mn) and Volume (Units) Forecast By Country

12.2.1. Mexico

12.2.2. Argentina

12.2.3. Rest of Latin America

12.3. Market Size (US$ Mn) Forecast By Product

12.3.1. Drug Eluting Stent (DES)

12.3.2. Bare Metal Stent (BMS)

12.3.3. Bioresorbable Vascular Stent (BVS)

12.4. Market Size (US$ Mn) Forecast By Raw Material

12.4.1. Cobalt Chromium

12.4.2. Stainless Steel

12.4.3. Platinum – Chromium

12.4.4. Nickel – Titanium

12.4.5. Polymer

12.5. Market Size (US$ Mn) Forecast By End User

12.5.1. Hospitals

12.5.2. Ambulatory Surgical Centers

12.5.3. Cardiac Catheterization Laboratories

12.6. Market Attractiveness Analysis

12.6.1. By Country

12.6.2. By Product

12.6.3. By Raw Material

12.6.4. By End User

12.7. Prominent Trends

12.8. Drivers and Restraints: Impact Analysis

13. Brazil Coronary Stents Market Analysis and Forecast

13.1. Introduction

13.1.1. Basis Point Share (BPS) Analysis By Country

13.1.2. Y-o-Y Growth Projections By Country

13.2. Market Size (US$ Mn) Forecast By Product

13.2.1. Drug Eluting Stent (DES)

13.2.2. Bare Metal Stent (BMS)

13.2.3. Bioresorbable Vascular Stent (BVS)

13.3. Market Size (US$ Mn) Forecast By Raw Material

13.3.1. Cobalt Chromium

13.3.2. Stainless Steel

13.3.3. Platinum – Chromium

13.3.4. Nickel – Titanium

13.3.5. Polymer

13.4. Market Size (US$ Mn) Forecast By End User

13.4.1. Hospitals

13.4.2. Ambulatory Surgical Centers

13.4.3. Cardiac Catheterization Laboratories

13.5. Market Attractiveness Analysis

13.5.1. By Product

13.5.2. By Raw Material

13.5.3. By End User

14. Western Europe Coronary Stents Market Analysis and Forecast

14.1. Introduction

14.1.1. Basis Point Share (BPS) Analysis By Country / Region

14.1.2. Y-o-Y Growth Projections By Country

14.2. Market Size (US$ Mn) and Volume (Units) Forecast By Country / Region

14.2.1. Germany

14.2.2. France

14.2.3. Italy

14.2.4. Spain

14.2.5. U.K.

14.2.6. BENELUX

14.2.7. Rest of Western Europe

14.3. Market Size (US$ Mn) Forecast By Product

14.3.1. Drug Eluting Stent (DES)

14.3.2. Bare Metal Stent (BMS)

14.3.3. Bioresorbable Vascular Stent (BVS)

14.4. Market Size (US$ Mn) Forecast By Raw Material

14.4.1. Cobalt Chromium

14.4.2. Stainless Steel

14.4.3. Platinum – Chromium

14.4.4. Nickel – Titanium

14.4.5. Polymer

14.5. Market Size (US$ Mn) Forecast By End User

14.5.1. Hospitals

14.5.2. Ambulatory Surgical Centers

14.5.3. Cardiac Catheterization Laboratories

14.6. Market Attractiveness Analysis

14.6.1. By Country

14.6.2. By Product

14.6.3. By Raw Material

14.6.4. By End User

14.7. Prominent Trends

14.8. Drivers and Restraints: Impact Analysis

15. Eastern Europe Coronary Stents Market Analysis and Forecast

15.1. Introduction

15.1.1. Basis Point Share (BPS) Analysis By Country

15.1.2. Y-o-Y Growth Projections By Country

15.2. Market Size (US$ Mn) and Volume (Units) Forecast By Country

15.2.1. Russia

15.2.2. Poland

15.2.3. Rest of Eastern Europe

15.3. Market Size (US$ Mn) Forecast By Product

15.3.1. Drug Eluting Stent (DES)

15.3.2. Bare Metal Stent (BMS)

15.3.3. Bioresorbable Vascular Stent (BVS)

15.4. Market Size (US$ Mn) Forecast By Raw Material

15.4.1. Cobalt Chromium

15.4.2. Stainless Steel

15.4.3. Platinum – Chromium

15.4.4. Nickel – Titanium

15.4.5. Polymer

15.5. Market Size (US$ Mn) Forecast By End User

15.5.1. Hospitals

15.5.2. Ambulatory Surgical Centers

15.5.3. Cardiac Catheterization Laboratories

15.6. Market Attractiveness Analysis

15.6.1. By Country

15.6.2. By Product

15.6.3. By Raw Material

15.6.4. By End User

15.7. Prominent Trends

15.8. Drivers and Restraints: Impact Analysis



【レポートのキーワード】

冠動脈ステント、薬剤溶出型ステント(DES)、ベアメタルステント(BMS)、生体吸収性脈管用ステント(BVS)

★調査レポート[冠動脈ステントの世界市場ー産業および機会分析ー2016-2026:薬剤溶出型ステント(DES)、ベアメタルステント(BMS)、生体吸収性脈管用ステント(BVS)] (コード:FMI612040)販売に関する免責事項を必ずご確認ください。
★調査レポート[冠動脈ステントの世界市場ー産業および機会分析ー2016-2026:薬剤溶出型ステント(DES)、ベアメタルステント(BMS)、生体吸収性脈管用ステント(BVS)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆